Hansson JH, Suzuki H, Schild L, Rossier B, Lifton RP
Genetic heterogeneity of Liddle's syndrome
AHA Council for High Blood Pressure Research
Hypertension (Sep) 26:537 (abst) 1995

Liddle's syndrome, first described in 1963, is an autosomal dominant form of human hypertension characterized by severe hypertension, variable hypokalemia, and negligible secretion of aldosterone (hence pseudoaldosteronism). The hypertension responds well to triamterene, a specific inhibitor of the collecting duct apical membrane sodium channel. These findings suggested that the hypertension might be caused by excessive sodium reabsorption in the distal nephron via a mineralocorticoid-regulated, amiloride-sensitive, epithelial sodium channel which is indirectly coupled to potassium secretion. This channel is comprised of three subunits (alpha, beta and gamma). Last year, this same group demonstrated complete linkage to an abnormal beta subunit of the epithelial sodium channel in Liddle's original kindred (Cell 79: 407-414, 1994). There was a premature stop codon that truncated the cytoplasmic carboxyl terminus in affected subunits. Analysis of four other kindreds showed either premature terminations or frameshift mutations in this same gene. These findings were the first identification of the molecular basis of an inherited from of hypertension, and motivated may researchers to study candidate genes in the hypertensive populations. However, some Liddle's kindreds have normal beta subunits, which motivated them to study other subunits of this channel. They found a point mutation which introduced a premature stop codon, truncating 76 aminoacids. Expression of the mutant protein in the context of normal alpha and beta subunits revealed a four fold increase in sodium conductance. These findings indicate that Liddle's syndrome is genetically heterogeneous, involving at least two subunits of the epithelial sodium channel. (R. Star)

To go back use the BACK button on your browser.
Otherwise click on the desired link to this article below:
AHA Council for High Blood Pressure Research
H: Pathophysiology : Genetics
H: Special problems : Endocrine hypertension